Update of P2Y receptor pharmacology: IUPHAR Review 27
Citations Over TimeTop 1% of 2020 papers
Abstract
Eight G protein-coupled P2Y receptor subtypes respond to extracellular adenine and uracil mononucleotides and dinucleotides. P2Y receptors belong to the δ group of rhodopsin-like GPCRs and contain two structurally distinct subfamilies: P2Y1 , P2Y2 , P2Y4 , P2Y6 , and P2Y11 (principally Gq protein-coupled P2Y1 -like) and P2Y12-14 (principally Gi protein-coupled P2Y12 -like) receptors. Brain P2Y receptors occur in neurons, glial cells, and vasculature. Endothelial P2Y1 , P2Y2 , P2Y4 , and P2Y6 receptors induce vasodilation, while smooth muscle P2Y2 , P2Y4 , and P2Y6 receptor activation leads to vasoconstriction. Pancreatic P2Y1 and P2Y6 receptors stimulate while P2Y13 receptors inhibits insulin secretion. Antagonists of P2Y12 receptors, and potentially P2Y1 receptors, are anti-thrombotic agents, and a P2Y2 /P2Y4 receptor agonist treats dry eye syndrome in Asia. P2Y receptor agonists are generally pro-inflammatory, and antagonists may eventually treat inflammatory conditions. This article reviews recent developments in P2Y receptor pharmacology (using synthetic agonists and antagonists), structure and biophysical properties (using X-ray crystallography, mutagenesis and modelling), physiological and pathophysiological roles, and present and potentially future therapeutic targeting.
Related Papers
- → Diisothiocyanate derivatives as potent, insurmountable antagonists of P2Y6 nucleotide receptors(2004)165 cited
- → P2X7 nucleotide receptor activation enhances IFNγ‐induced type II nitric oxide synthase activity in BV‐2 microglial cells(2003)95 cited
- → Agonist‐selective signaling of G protein‐coupled receptor: Mechanisms and implications(2010)69 cited
- → Metabotropic receptors for ATP and UTP: exploring the correspondence between native and recombinant nucleotide receptors(1998)156 cited
- → Use of N-ethylmaleimide to directly determine the proportion of β-adrenergic receptors exhibiting high affinity for agonists on human mononuclear leukocyte membranes(1989)1 cited